• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [6756 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2015 National Institute for Health and Care Excellence (NICE) Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab. NICE technology appraisal guidance 357
2015 National Institute for Health and Care Excellence (NICE) Tolvaptan for treating autosomal dominant polycystic kidney disease. NICE technology appraisal guidance 358
2015 National Institute for Health and Care Excellence (NICE) Idelalisib for treating chronic lymphocytic leukaemia. NICE technology appraisal guidance 359
2015 National Institute for Health and Care Excellence (NICE) Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal). NICE technology appraisal guidance 362
2015 National Institute for Health and Care Excellence (NICE) Ledipasvir-sofosbuvir for treating chronic hepatitis C. NICE technology appraisal guidance 363
2015 National Institute for Health and Care Excellence (NICE) Ombitasvir-paritaprevir-ritonavir with or without dasabuvir for treating chronic hepatitis C. NICE technology appraisal guidance 365
2015 National Institute for Health and Care Excellence (NICE) Pembrolizumab for advanced melanoma not previously treated with ipilimumab. NICE technology appraisal guidance 366
2015 National Institute for Health and Care Excellence (NICE) Vortioxetine for treating major depressive episodes. NICE technology appraisal guidance 367
2015 National Institute for Health and Care Excellence (NICE) Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears. NICE technology appraisal guidance 369
2015 National Institute for Health and Care Excellence (NICE) Bortezomib for previously untreated mantle cell lymphoma. NICE technology appraisal guidance 370
2015 National Institute for Health and Care Excellence (NICE) Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis. NICE technology appraisal guidance 373
2015 National Institute for Health and Care Excellence (NICE) Repetitive transcranial magnetic stimulation for depression. NICE interventional procedures guidance 542
2015 National Institute for Health and Care Excellence (NICE) Joint distraction for ankle osteoarthritis. NICE interventional procedures guidance 538
2015 National Institute for Health and Care Excellence (NICE) Radiofrequency ablation for symptomatic interdigital (Morton's) neuroma. NICE interventional procedures guidance 539
2015 National Institute for Health and Care Excellence (NICE) Electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux disease. NICE interventional procedures guidance 540
2015 National Institute for Health and Care Excellence (NICE) Insertion of a subretinal prosthesis system for retinitis pigmentosa. NICE interventional procedures guidance 537
2015 National Institute for Health and Care Excellence (NICE) Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyes. NICE interventional procedures guidance 534
2015 National Institute for Health and Care Excellence (NICE) Living-donor liver transplantation. NICE interventional procedures guidance 535
2015 National Institute for Health and Care Excellence (NICE) Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention. NICE interventional procedures guidance 536
2015 National Institute for Health and Care Excellence (NICE) Implanting a baroreceptor stimulation device for resistant hypertension. NICE interventional procedures guidance 533
2015 National Institute for Health and Care Excellence (NICE) Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer. NICE interventional procedures guidance 532
2015 National Institute for Health and Care Excellence (NICE) Preoperative high dose rate brachytherapy for rectal cancer. NICE interventional procedures guidance 531
2015 National Institute for Health and Care Excellence (NICE) Transcranial direct current stimulation (tDCS) for depression. NICE interventional procedures guidance 530
2015 National Institute for Health and Care Excellence (NICE) Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section. NICE interventional procedures guidance 528
2015 National Institute for Health and Care Excellence (NICE) Joint distraction for knee osteoarthritis without alignment correction. NICE interventional procedures guidance 529
2015 National Institute for Health and Care Excellence (NICE) Suture fixation of acute disruption of the distal tibiofibular syndesmosis. NICE interventional procedures guidance 521
2015 National Institute for Health and Care Excellence (NICE) Ultrasound-enhanced, catheter-directed thrombolysis for deep vein thrombosis. NICE interventional procedures guidance 523
2015 National Institute for Health and Care Excellence (NICE) Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism. NICE interventional procedures guidance 524
2015 National Institute for Health and Care Excellence (NICE) Electrotherapy for the treatment of haemorrhoids. NICE interventional procedures guidance 525
2015 National Institute for Health and Care Excellence (NICE) Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache. NICE interventional procedures guidance 527
2015 National Institute for Health and Care Excellence (NICE) Insertion of an epiretinal prosthesis for retinitis pigmentosa. NICE interventional procedures guidance 519
2015 National Institute for Health and Care Excellence (NICE) Radiofrequency ablation for gastric antral vascular ectasia. NICE interventional procedures guidance 520
2015 National Institute for Health and Care Excellence (NICE) Insertion of a balloon device to disimpact an engaged fetal head before an emergency caesarean section. NICE interventional procedures guidance 515
2015 National Institute for Health and Care Excellence (NICE) Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation. NICE interventional procedures guidance 516
2015 National Institute for Health and Care Excellence (NICE) Insertion of endobronchial nitinol coils to improve lung function in emphysema. NICE interventional procedures guidance 517
2015 National Institute for Health and Care Excellence (NICE) Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes. NICE interventional procedures guidance 518
2015 National Institute for Health and Care Excellence (NICE) Flexible endoscopic treatment of a pharyngeal pouch. NICE interventional procedures guidance 513
2015 National Institute for Health and Care Excellence (NICE) Implantation of a shock or load absorber for mild to moderate symptomatic medial knee osteoarthritis. NICE interventional procedures guidance 512
2015 National Institute for Health and Care Excellence (NICE) Open reduction of slipped capital femoral epiphysis. NICE interventional procedures guidance 511
2015 National Institute for Health and Care Excellence (NICE) Hysteroscopic metroplasty of a uterine septum for primary infertility. NICE interventional procedures guidance 509
2015 National Institute for Health and Care Excellence (NICE) Hysteroscopic metroplasty of a uterine septum for recurrent miscarriage. NICE interventional procedures guidance 510
2015 National Institute for Health and Care Excellence (NICE) Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C. NICE medical technologies guidance 27
2015 National Institute for Health and Care Excellence (NICE) Tegaderm CHG securement dressing for vascular access sites in critically ill adults. NICE medical technologies guidance 25
2015 National Institute for Health and Care Excellence (NICE) The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters. NICE medical technologies guidance 24
2015 National Institute for Health and Care Excellence (NICE) VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions. NICE diagnostics guidance 19
2015 National Institute for Health and Care Excellence (NICE) Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay). NICE diagnostics guidance 18
2015 Canary Health Service [Alternatives to isotopic techniques in the detection of the sentinel lymph node in breast cancer]
2015 Canary Health Service [Cost-effectiveness of neonatal screening for 3-hydroxy-3-methylglutaric aciduria (HMG)]
2015 Canary Health Service [Effectiveness and safety of hyaluronic acid in the treatment of osteoarthritis of the knee, hip and other joint locations]
2015 Canary Health Service [Effectiveness, safety and cost-effectiveness of epidural adhesiolysis for the treatment of failed back surgery syndrome]
2015 Canary Health Service [Effectiveness, safety and cost-effectiveness of cholecystectomy versus conservative treatment for uncomplicated symptomatic cholelithiasis or acute cholecystitis]
2015 Canary Health Service [Effectiveness, safety and cost-effectiveness of real-time continuous interstitial glucose monitoring systems (SMCG-TR) for type 1 and 2 diabetes mellitus]
2015 Canary Health Service [Monitoring study protocol (part I): endobronchial valves for persistent air leakage]
2015 Canary Health Service [Monetary value of a quality-adjusted life year: empirical estimation of the opportunity cost in the national health system]
2015 Center for Drug Evaluation (CDE) [Transcatheter aortic valve implantation (TAVI) HTA report]
2015 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Care models of pharmaceutical provision in health and social care centres]